Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALK-negative inflammatory myofibroblastic tumor with an undetermined differentiation direction: A case report and review of the literature. | Medicine (Baltimore) | 2026 | 41560086 | PubTator, text mining | PubMed |
| Diagnostic pitfall: BCOR immunoreactivity in a molecularly confirmed astroblastoma, MN1-altered (HGNET-MN1). | Clin Neuropathol | 2026 | 41553165 | PubTator, text mining | PubMed |
| Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study. | Am J Hematol | 2026 | 41549790 | PubTator, text mining | PubMed |
| BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia. | Ann Hematol | 2026 | 41549155 | PubTator, text mining | PubMed |
| A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers. | ESMO Open | 2026 | 41547215 | PubTator, text mining | PubMed |
| Phase 1B pilot study of itacitinib with alemtuzumab in patients with T-cell prolymphocytic leukemia. | Blood Neoplasia | 2026 | 41536780 | PubTator, text mining | PubMed |
| Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study. | Leukemia | 2026 | 41535568 | PubTator, text mining | PubMed |
| Precision Medicine Program in Chinese Pediatric Patients With Sarcoma. | JCO Precis Oncol | 2026 | 41533994 | PubTator, text mining | PubMed |
| MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities. | Blood Adv | 2026 | 41529224 | PubTator, text mining | PubMed |
| Prospective implementation of an aqueous humor liquid biopsy platform informs clinical diagnosis and management of retinoblastoma and other intraocular lesions. | NPJ Precis Oncol | 2026 | 41526667 | PubTator, text mining | PubMed |
| Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat. | Leukemia | 2026 | 41526614 | PubTator, text mining | PubMed |
| A Case Report of Primitive Myxoid Mesenchymal Tumor of Infancy (PMMTI) with BCOR-ITD Genetic Alteration in the Sinonasal Cavity and Review of Literature. | Head Neck Pathol | 2026 | 41504826 | PubTator, text mining | PubMed |
| Undifferentiated Round Cell Sarcomas: Retrospective Morphological, Immunohistochemical, and Molecular Re-Evaluation Including a Unique Case of ZC3H7B::BCOR Fusion. | APMIS | 2026 | 41494974 | PubTator, text mining | PubMed |
| Polycomb repressive complexes as therapeutic targets in hematologic malignancies. | Exp Hematol | 2026 | 41443386 | PubTator, text mining | PubMed |
| Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis. | Br J Haematol | 2026 | 41386566 | PubTator, text mining | PubMed |
| A Rare BCOR-ITD Musculoskeletal Sarcoma in an Adult Male Patient. | Int J Surg Pathol | 2026 | 41385246 | PubTator, text mining | PubMed |
| BCOR Mutations Identify a Clinically Aggressive Subset of Pediatric Rhabdomyosarcoma. | Fetal Pediatr Pathol | 2026 | 41355507 | PubTator, text mining | PubMed |
| Central Nervous System Embryonal Tumors. | Neuroimaging Clin N Am | 2026 | 41274772 | PubTator, text mining | PubMed |
| Compound genetic burden in oculo-facio-cardio-dental (OFCD) syndrome: surgical risk stratification with co-occurring BCOR and MYLK mutations. | Ophthalmic Genet | 2026 | 41236190 | PubTator, text mining | PubMed |
| BCOR Mutations Deregulate Cell Cycle and Hypoxic Adaptation Pathways in Retinoblastoma. | Mol Cancer Res | 2026 | 41191430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=5